First Trust Advisors LP Biomarin Pharmaceutical Inc Transaction History

First Trust Advisors LP

$101 Billion
Q3 2024

A detailed history of First Trust Advisors LP transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, First Trust Advisors LP holds 467,298 shares of BMRN stock, worth $31 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

467,298

Previous 404,024 15.66%

Holding current value

$31 Million

Previous $33.3 Million 1.25%

% of portfolio

0.03%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$69.02 - $93.84 $4.37 Million - $5.94 Million	63,274 Added 15.66%	467,298 $32.8 Million
Q2 2024 Aug 13, 2024	SELL	$74.43 - $92.22 $5.4 Million - $6.69 Million	-72,507 Reduced 15.22%	404,024 $33.3 Million
Q1 2024 May 13, 2024	SELL	$83.81 - $99.0 $8.67 Million - $10.2 Million	-103,400 Reduced 17.83%	476,531 $41.6 Million
Q4 2023 Feb 13, 2024	BUY	$76.22 - $98.51 $4.31 Million - $5.57 Million	56,532 Added 10.8%	579,931 $55.9 Million
Q3 2023 Nov 13, 2023	BUY	$85.07 - $94.48 $1.48 Million - $1.65 Million	17,438 Added 3.45%	523,399 $46.3 Million
Q2 2023 Aug 14, 2023	BUY	$86.68 - $100.3 $1.05 Million - $1.21 Million	12,099 Added 2.45%	505,961 $43.9 Million
Q1 2023 May 15, 2023	SELL	$87.74 - $117.27 $724,907 - $968,884	-8,262 Reduced 1.65%	493,862 $48 Million
Q4 2022 Feb 09, 2023	SELL	$80.93 - $108.63 $4.3 Million - $5.78 Million	-53,169 Reduced 9.57%	502,124 $52 Million
Q3 2022 Nov 14, 2022	SELL	$82.16 - $96.94 $3.54 Million - $4.17 Million	-43,066 Reduced 7.2%	555,293 $47.1 Million
Q2 2022 Aug 12, 2022	SELL	$71.48 - $86.85 $378,057 - $459,349	-5,289 Reduced 0.88%	598,359 $49.6 Million
Q1 2022 May 13, 2022	SELL	$74.28 - $92.69 $38.7 Million - $48.3 Million	-521,126 Reduced 46.33%	603,648 $46.5 Million
Q4 2021 Feb 08, 2022	BUY	$71.72 - $91.47 $3 Million - $3.83 Million	41,888 Added 3.87%	1,124,774 $99.4 Million
Q3 2021 Nov 15, 2021	SELL	$74.77 - $85.47 $9.94 Million - $11.4 Million	-132,988 Reduced 10.94%	1,082,886 $83.7 Million
Q2 2021 Aug 16, 2021	BUY	$75.51 - $84.79 $6.51 Million - $7.31 Million	86,213 Added 7.63%	1,215,874 $101 Million
Q1 2021 May 14, 2021	BUY	$74.73 - $90.69 $22.4 Million - $27.1 Million	299,286 Added 36.04%	1,129,661 $85.3 Million
Q4 2020 Feb 02, 2021	SELL	$72.61 - $90.2 $13.4 Million - $16.6 Million	-184,481 Reduced 18.18%	830,375 $72.8 Million
Q3 2020 Nov 05, 2020	SELL	$71.87 - $131.03 $9.34 Million - $17 Million	-129,950 Reduced 11.35%	1,014,856 $77.2 Million
Q2 2020 Jul 22, 2020	BUY	$79.55 - $124.22 $30.9 Million - $48.2 Million	387,808 Added 51.23%	1,144,806 $141 Million
Q1 2020 May 06, 2020	SELL	$71.37 - $96.85 $7.79 Million - $10.6 Million	-109,093 Reduced 12.6%	756,998 $64 Million
Q4 2019 Feb 03, 2020	BUY	$64.27 - $86.37 $569,817 - $765,756	8,866 Added 1.03%	866,091 $73.2 Million
Q3 2019 Nov 04, 2019	SELL	$67.4 - $85.11 $26.4 Million - $33.3 Million	-391,836 Reduced 31.37%	857,225 $57.8 Million
Q2 2019 Jul 30, 2019	SELL	$80.35 - $93.9 $1.03 Million - $1.21 Million	-12,847 Reduced 1.02%	1,249,061 $107 Million
Q1 2019 May 09, 2019	BUY	$84.2 - $98.62 $14.7 Million - $17.2 Million	174,499 Added 16.05%	1,261,908 $112 Million
Q4 2018 Feb 07, 2019	SELL	$80.14 - $106.07 $11.2 Million - $14.9 Million	-140,091 Reduced 11.41%	1,087,409 $92.6 Million
Q3 2018 Oct 25, 2018	BUY	$93.92 - $105.72 $49.2 Million - $55.4 Million	523,649 Added 74.4%	1,227,500 $119 Million
Q2 2018 Aug 02, 2018	BUY	$76.01 - $99.03 $6.65 Million - $8.66 Million	87,468 Added 14.19%	703,851 $66.3 Million
Q1 2018 Apr 23, 2018	BUY	$77.67 - $92.63 $2.37 Million - $2.83 Million	30,545 Added 5.21%	616,383 $50 Million
Q4 2017 Feb 08, 2018	BUY	$80.76 - $95.13 $880,284 - $1.04 Million	10,900 Added 1.9%	585,838 $52.2 Million
Q3 2017 Oct 24, 2017	BUY	$80.6 - $94.95 $46.3 Million - $54.6 Million	574,938	574,938 $53.5 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.3B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Biomarin Pharmaceutical Inc Transaction History